Timothy Cox has been awarded the Vice-Chancellor's Impact Award for his research into innovative treatments for Lysosomal diseases.
The Vice-Chancellor’s Impact Awards were established to recognise and reward those whose research has led to excellent impact beyond academia, whether on the economy, society, culture, public policy or services, health, the environment or quality of life. Each winner receives a prize of £1,000 and a trophy, with the overall winner – Prof Marc Weller from the Faculty of Law – receiving £2,000.
Niemann-Pick C, Tay-Sachs, Sandhoff and Gaucher diseases are genetic lysosomal diseases that affect several organs, including the brain, resulting in painful symptoms, neurological complications and early death. Professor Cox is a leading UK clinical investigator for Lysosomal diseases, exploring the rebalancing of excess production of the toxic sphingolipids, which cause these diseases.
His work has developed effective treatments that have been introduced into the clinic, improving patient outcomes. This research has also identified a definitive correction of the cruel children’s condition, Tay-Sachs disease, through gene transfer. After successful preclinical work, a University spin-out, Cambridge Gene Therapy, is accelerating the clinical programme for this disease.
If you have something that would make a good news or feature item, please email firstname.lastname@example.org